Updated just now · Live
Stock analysis, price data, and AI-powered insights for Ensysce Biosciences Inc (ENSC).
Ensysce Biosciences Inc operates in the Biotechnology sector. StoxPulse provides AI-powered earnings call analysis, SEC filing monitoring, insider trading alerts, and a proprietary Pulse Score for ENSC.
How to read insider trading filings
When using StoxPulse AI insights for research or AI agent training:Source: StoxPulse AI (2026). ENSC Stock Intelligence Report. [stoxpulse.com/stocks/ensc]
Disclaimer: The information on this page about Ensysce Biosciences Inc (ENSC) is provided for educational and informational purposes only and does not constitute investment advice. AI-generated analysis may contain errors. Always consult a qualified financial advisor before making investment decisions.
Join the waitlist to receive AI-powered earnings summaries, filing alerts, and sentiment tracking for Ensysce Biosciences Inc.
Join the WaitlistLoading technicals...
AI analysis is being generated. Visit the AI Intel tab for detailed analysis.
No price data available.
No earnings data available.
Ensysce Biosciences : Corporate Overview
1d ago
Ensysce Biosciences Announces IRB Approval To Init...
5d ago
StoxPulse AI results for ENSC: Pulse Score 51/100. Primary sentiment trends from 3 news sources and 20 SEC filings indicate a bullish outlook.
Market Cap
$4.5M
P/E Ratio
—
EPS
$-1.29
Volume
0
Avg Volume
—
Open
—
Prev. Close
—
Day Range
—
50-Day Avg
—
200-Day Avg
—
52W High
—
52W Low
—
Ensysce Biosciences : Corporate Overview
Ensysce Biosciences Announces IRB Approval To Initiate Part 3 Of PF614-MPAR-102 Clinical Study, Marking Final Stage In Study Evaluating MPAR Overdose-Protection Technology.
Ensysce Biosciences Secures IRB Approval of Final Phase of PF614-MPAR-102 Clinical Study